Evidence map›Paper›PMID 24412415›Full record

ReviewBiotechnology advances

Advances in repairing the degenerate retina by rod photoreceptor transplantation.

Rachael A Pearson

Open access · hybridAbstract readReview
In one paragraph

Review in Biotechnology advances. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 50 citations in OpenAlex.

  1. Congenital Stationary Night Blindness: Clinical and Genetic Features.International journal of molecular sciences · 2022
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Deafferented Adult Rod Bipolar Cells Create New Synapses with Photoreceptors to Restore Vision.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2017
    Article
  10. Article
  11. Article
  12. Grafted c-kitStem cell research & therapy · 2016
    Article
  13. Article
  14. Review
  15. Efficacy and Safety of Human Retinal Progenitor Cells.Translational vision science & technology · 2016
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Rachael A PearsonDepartment of Genetics, UCL Institute of Ophthalmology, 11-43 Bath Street, London EC1V 9EL, UK. Electronic address: rachael.pearson@ucl.ac.uk.
University College London · GB

Funding

Biotechnology and Biological Sciences Research Council BB/I013636/1Medical Research Council G03000341Medical Research Council MR/J004553/1Wellcome Trust 086128/Z/08/Z
6 · The paper itself

Abstract

Despite very different aetiologies, age-related macular degeneration (AMD) and most inherited retinal disorders culminate in the same final common pathway, loss of the light-sensitive photoreceptors. There are few clinical treatments and none can reverse the loss of vision. Photoreceptor replacement by transplantation is proposed as a broad treatment strategy applicable to all degenerations. The past decade has seen a number of landmark achievements in this field, which together provide strong justification for continuing investigation into photoreceptor replacement strategies. These include proof of principle for restoring vision by rod-photoreceptor transplantation in mice with congenital stationary night blindness and advances in stem cell biology, which have led to the generation of complete optic structures in vitro from embryonic stem cells. The latter represents enormous potential for generating suitable and renewable donor cells with which to achieve the former. However, there are still challenges presented by the degenerating recipient retinal environment that must be addressed as we move to translating these technologies towards clinical application.

Indexed as

Cell TransplantationEmbryonic Stem CellsRetinaRetinal DegenerationRetinal Rod Photoreceptor CellsAnimalsHaplorhiniHumansMiceDegenerationDevelopmentEyeGliosisNeural retinaPhotoreceptorStem cellsTransplantationVisual function

Identifiers

PMID24412415
PMCPMC4070022
OpenAlexW1989585538

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.